Evidence map›Paper›PMID 20555032›Full record

ArticleEndocrinology2010

IGF-I activation of the AKT pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects.

Kelly Cleveland-Donovan, Laura A Maile, William G Tsiaras, Tamara Tchkonia, James L Kirkland, Charlotte M Boney

Open access · greenAbstract read
In one paragraph

Article in Endocrinology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Activation of mTOR: a culprit of Alzheimer's disease?Neuropsychiatric disease and treatment · 2015
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Kelly Cleveland-DonovanDepartment of Pediatrics, Rhode Island Hospital and Alpert Medical School of Brown University, Providence, Rhode Island 02903, USA.
Laura A Maile
William G Tsiaras
Tamara Tchkonia
James L Kirkland
Charlotte M Boney
Brown University · USMayo Clinic · USRhode Island Hospital · USUniversity of North Carolina at Chapel Hill · US

Funding

The Somatotropic Axis and Health Aging: A Search for MechanismsP01AG031736 · NIA · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI KIRKLAND, JAMES L. · 2009 to 2013
$8.4M
Effect of Aging on Preadipocyte DifferentiationR01AG013925 · NIA · MAYO CLINIC ROCHESTER · PI KIRKLAND, JAMES L. · 1997 to 2012
$3.7M
The Role of Src Kinases in IGF-I-Mediated AdipogenesisR01DK059339 · NIDDK · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI BONEY, CHARLOTTE MARIE · 2002 to 2006
$1.0M
NIA NIH HHS P01 AG031736NIA NIH HHS P01AG031736NIA NIH HHS R01 AG013925NIA NIH HHS R01AG13925NIDDK NIH HHS R01 DK059339NIDDK NIH HHS R01DK59339
6 · The paper itself

Abstract

Obesity morbidity is associated with excess visceral adiposity, whereas sc adipose tissue is much less metabolically hazardous. Human abdominal sc preadipocytes have greater capacity for proliferation, differentiation, and survival than omental preadipocytes. IGF-I is a critical mediator of preadipocyte proliferation, differentiation, and survival through multiple signaling pathways. We investigated IGF-I action in primary cultures of human preadipocytes isolated from sc and omental adipose tissue of obese subjects. IGF-I-stimulated DNA synthesis was significantly lower in omental compared with sc preadipocytes. IGF-I phosphorylation of the IGF-I receptor and the ERK pathway was comparable in sc and omental cells. However, omental preadipocytes had decreased insulin receptor substrate (IRS)-1 protein associated with increased IRS-1-serine(636/639) phosphorylation and degradation. IGF-I-stimulated phosphorylation of AKT on serine(473) but not threonine(308) was decreased in omental cells, and activation of downstream targets, including S6Kinase, glycogen synthase kinase-3, and Forkhead box O1 was also impaired. CyclinD1 abundance was decreased in omental cells due to increased degradation. Over-expression of IRS-1 by lentivirus in omental preadipocytes increased IGF-I-stimulated AKT-serine(473) phosphorylation. The mammalian target of rapamycin (mTOR)-Rictor complex regulates phosphorylation of AKT-serine(473) in 3T3-L1 adipocytes, but knockdown of Rictor by lentivirus-delivered short hairpin RNA in sc preadipocytes did not affect AKT-serine(473) phosphorylation by IGF-I. These data reveal an intrinsic defect in IGF-I activation of the AKT pathway in omental preadipocytes from obese subjects that involves IRS-1 but probably not mTOR-Rictor complex. We conclude that impaired cell cycle regulation by AKT contributes to the distinct growth phenotype of preadipocytes in visceral fat of obese subjects.

Indexed as

3T3-L1 CellsAdipocytes, WhiteAdultAnimalsCell Culture TechniquesCell CycleCells, CulturedDown-RegulationEnzyme ActivationFemaleHumansInsulin-Like Growth Factor IIntra-Abdominal FatMaleMiceMiddle AgedInsulin-Like Growth Factor IProto-Oncogene Proteins c-akt

Identifiers

PMID20555032
PMCPMC2940538
OpenAlexW2114427284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.